Malaria vaccines–targeting infected hepatocytes
- 1 November 2000
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 6 (11) , 1218-1219
- https://doi.org/10.1038/81315
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3Nature Medicine, 2000
- Cytotoxic T-Lymphocyte Epitopes for HLA-B53 and Other HLA Types in the Malaria Vaccine Candidate Liver-Stage Antigen 3Infection and Immunity, 2000
- Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a RecombinantPlasmodium falciparumMalaria VaccineThe Journal of Infectious Diseases, 1999
- From genomics to vaccines: Malaria as a model systemNature Medicine, 1998
- Chromosome 2 Sequence of the Human Malaria ParasitePlasmodium falciparumScience, 1998
- Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA VaccineScience, 1998
- A protein particle vaccine containing multiple malaria epitopesNature Biotechnology, 1997
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Immunization of man against sporozite-induced falciparum malariaThe Lancet Healthy Longevity, 1973
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium bergheiNature, 1967